Ángel Vila-Rovira
Biographic Data
| ID | 7761964 |
|---|---|
| NAME | Ángel Vila-Rovira |
| GIVEN NAMES | Ángel |
| FAMILY NAME | Vila-Rovira |
| SIGNATURE | VILA-ROVIRA Á |
| AFFILIATIONS | Universitat Autonòma de Barcelona |
| ORCID | 0000-0002-9543-8907 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Covid19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of Sars-COV-2 infection
COVID19-related deaths represented more than 20 % of all-cause mortality occurred among middle-aged and older adults during the first wave of the pandemic in the region. A considerable proportion (around 10 %) of these COVID19-related deaths could be attributed to other concomitant causes. Theoretically COVID19-excluded subjects (PCR-negative) suffered ten-times greater all-cause mortality than healthy/unrelated-COVID19 subjects, which points to …
Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years
Our data supports a benefit of PPV23 against ischaemic stroke among the general population over 60 years, suggesting a possible protective role of pneumococcal vaccination against some acute thrombotic events
No prominent works on this page.
Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years
Our data supports a benefit of PPV23 against ischaemic stroke among the general population over 60 years, suggesting a possible protective role of pneumococcal vaccination against some acute thrombotic events
Covid19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of Sars-COV-2 infection
COVID19-related deaths represented more than 20 % of all-cause mortality occurred among middle-aged and older adults during the first wave of the pandemic in the region. A considerable proportion (around 10 %) of these COVID19-related deaths could be attributed to other concomitant causes. Theoretically COVID19-excluded subjects (PCR-negative) suffered ten-times greater all-cause mortality than healthy/unrelated-COVID19 subjects, which points to …
Cohort (2 works) · Cohort study (2 works) · Environmental health (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Pediatrics (2 works) · Population (2 works) · Atherosclerosis and Cardiovascular Diseases (1 work) · Bacterial Infections and Vaccines (1 work) · Cause of death (1 work)